Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-02

Clinical Trial Update: Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin [Phase 1]

View source ↗

Summary

Phase I trial updating safety, tolerability, and action of OAP-189 in adults with type 2 diabetes on metformin; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OAP-189

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2020-11-02